EPIGENESIS.COM

Serial Number 76122100
606

Registration Progress

Application Filed
Aug 23, 2000
Under Examination
Jul 8, 2003
Approved for Publication
Mar 26, 2003
Published for Opposition
Apr 15, 2003
Registered

Trademark Image

EPIGENESIS.COM

Basic Information

Serial Number
76122100
Filing Date
August 23, 2000
Published for Opposition
April 15, 2003
Abandonment Date
July 14, 2006
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 14, 2006
Classes
005

Rights Holder

EPIGENESIS PHARMACEUTICALS LLC

03
Address
7 CLARKE DRIVE
CRANBURY, NJ 08512

Ownership History

EPIGENESIS Pharmaceuticals, Inc.

Original Applicant
03
Cranbury, NJ

EPIGENESIS Pharmaceuticals, Inc.

Owner at Publication
03
Cranbury, NJ

EPIGENESIS PHARMACEUTICALS, INC.

New Owner After Publication #1
03
CRANBURY, NJ

EPIGENESIS PHARMACEUTICALS LLC

New Owner After Publication #2
03
CRANBURY, NJ

Legal Representation

Attorney
Viviana Amzel

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Sep 13, 2006 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 13, 2006 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Dec 29, 2005 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 29, 2005 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 29, 2005 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 1, 2005 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 1, 2005 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 1, 2005 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 10, 2005 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 23, 2004 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 23, 2004 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 29, 2004 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 19, 2004 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 16, 2004 MAIL I PAPER RECEIVED Loading...
Jul 13, 2004 CFIT O CASE FILE IN TICRS Loading...
Jul 6, 2004 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 6, 2004 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 29, 2004 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 7, 2004 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 7, 2004 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 8, 2003 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 15, 2003 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 26, 2003 NPUB O NOTICE OF PUBLICATION Loading...
Jul 18, 2002 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 5, 2002 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 5, 2002 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 29, 2001 CNFR O FINAL REFUSAL MAILED Loading...
Aug 17, 2001 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 12, 2001 CNRT F NON-FINAL ACTION MAILED Loading...
Jan 24, 2001 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 23, 2001 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
Medical diagnostic and therapeutic preparations and devices, for administering same, sold filled, with, diagnostic and therapeutic preparations, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms, pharmaceutical preparations for testing and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostrate included
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
EPIGENESIS

Classification

International Classes
005